Literature DB >> 16146820

TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.

Michael A Teitell1, Mark A Lones, Sherrie L Perkins, Warren G Sanger, Mitchell S Cairo, Jonathan W Said.   

Abstract

Elevated T-cell leukemia-1 (TCL1) oncoprotein expression might promote human Burkitt lymphoma (BL) because increased TCL1 causes Burkitt-like lymphomas in TCL1 transgenic mice. Epstein-Barr virus (EBV) infection has been implicated as a cause of increased TCL1 expression in multiple BL cell lines, suggesting a critical connection between EBV and TCL1-induced BL. The TCL1 expression and EBV status of 14 sporadic pediatric BL cases was determined by immunohistochemical staining for TCL1 and in situ hybridization for EBV-encoded RNA (EBER). Our results showed TCL1 protein in 11 cases, predominantly in the nucleus with strong-intensity staining. EBER was positive in 4 cases, with 3 of these cases also TCL1+. In the 10 cases that were EBER-, TCL1 was strongly positive in 8. These data indicate that the TCL1 oncoprotein is expressed strongly in most pediatric BL cases. However, persistent EBV is not essential for increased TCL1 expression, although elevated TCL1 and c-MYC coexpression might cooperate in the development of most pediatric and adult BL cases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146820     DOI: 10.1309/77V7U4E03V69QHRR

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

2.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

3.  Epstein-Barr virus nuclear antigen 3C regulated genes in lymphoblastoid cell lines.

Authors:  Bo Zhao; Jessica C Mar; Seiji Maruo; Sungwook Lee; Benjamin E Gewurz; Eric Johannsen; Kristina Holton; Renee Rubio; Kenzo Takada; John Quackenbush; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-20       Impact factor: 11.205

4.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Authors:  Matthew J Frank; David W Dawson; Steven J Bensinger; Jason S Hong; Wendy M Knosp; Lizhong Xu; Cynthia E Balatoni; Eric L Allen; Rhine R Shen; Dafna Bar-Sagi; Gail R Martin; Michael A Teitell
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

5.  c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells.

Authors:  Nathalie Faumont; Stéphanie Durand-Panteix; Martin Schlee; Sebastian Grömminger; Marino Schuhmacher; Michael Hölzel; Gerhard Laux; Reinhard Mailhammer; Andreas Rosenwald; Louis M Staudt; Georg W Bornkamm; Jean Feuillard
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

6.  Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005.

Authors:  Sam M Mbulaiteye; Robert J Biggar; Kishor Bhatia; Martha S Linet; Susan S Devesa
Journal:  Pediatr Blood Cancer       Date:  2009-09       Impact factor: 3.167

7.  Clinicopathological study of sporadic Burkitt lymphoma in children.

Authors:  Hui Huang; Zhi-Liang Liu; Hua Zeng; Shou-Hua Zhang; Chuan-Sheng Huang; Hong-Yan Xu; Yan Wu; Song-Tao Zeng; Feng Xiong; Wen-Ping Yang
Journal:  Chin Med J (Engl)       Date:  2015-02-20       Impact factor: 2.628

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.